Petmed Express Inc PETS
We take great care to ensure that the data presented and summarized in this overview for PETMED EXPRESS INC is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding PETS
View all-
Jim Simons Renaissance Technologies LLC | New York, Ny1.27MShares$3.99 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA964KShares$3.02 Million0.0% of portfolio
-
Hotchkis & Wiley Capital Management LLC Los Angeles, CA827KShares$2.59 Million0.01% of portfolio
-
Black Rock Inc. New York, NY556KShares$1.74 Million0.0% of portfolio
-
Federated Hermes, Inc. Pittsburgh, PA481KShares$1.51 Million0.0% of portfolio
-
Dimensional Fund Advisors LP Austin, TX457KShares$1.43 Million0.0% of portfolio
-
Oaktop Capital Management Ii, L.P. Chatham, NJ436KShares$1.36 Million0.22% of portfolio
-
Arrowstreet Capital, Limited Partnership Boston, MA246KShares$771,3250.0% of portfolio
-
Geode Capital Management, LLC Boston, MA219KShares$685,7790.0% of portfolio
-
Ameriprise Financial Inc Minneapolis, MN143KShares$447,5050.0% of portfolio
Latest Institutional Activity in PETS
Top Purchases
Top Sells
About PETS
PetMed Express, Inc., together with its subsidiaries, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, health products, and other supplies for dogs, cats, and horses. It offers non-prescription medications and supplies, such as flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and supplies; and prescription medications, including heartworm preventatives, flea and tick preventatives, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes. The company also sells food, beds, crates, stairs, and other pet supplies. It sells its products through its Internet website; mobile app; telephone contact center; and direct mail/print, which includes brochures and postcards, as well as television advertising under the 1-800-PetMeds and PetMeds brands. PetMed Express, Inc. was incorporated in 1996 and is headquartered in Delray Beach, Florida.
Insider Transactions at PETS
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Aug 13
2025
|
Silvercape Investments LTD > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
101,000
+3.77%
|
$303,000
$3.17 P/Share
|
|
Aug 01
2025
|
Silvercape Investments LTD > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
118,200
+4.55%
|
$354,600
$3.21 P/Share
|
|
Jul 21
2025
|
Nina Capital Holdings Inc. > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
25,000
+0.96%
|
$75,000
$3.5 P/Share
|
|
Jul 18
2025
|
Silvercape Investments LTD > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
17,565
+0.74%
|
$52,695
$3.23 P/Share
|
|
Jul 17
2025
|
Silvercape Investments LTD > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
31,701
+1.34%
|
$95,103
$3.15 P/Share
|
|
Jul 02
2025
|
Silvercape Investments LTD > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
2,817
+0.12%
|
$8,451
$3.22 P/Share
|
|
Jul 01
2025
|
Silvercape Investments LTD > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
694
+0.03%
|
$2,082
$3.21 P/Share
|
|
Jun 03
2025
|
Nina Capital Holdings Inc. > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
25,000
+0.97%
|
$75,000
$3.94 P/Share
|
|
May 21
2025
|
Nina Capital Holdings Inc. > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
25,000
+0.98%
|
$75,000
$3.86 P/Share
|
|
May 20
2025
|
Silvercape Investments LTD > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
7,401
+0.32%
|
$22,203
$3.95 P/Share
|
|
Apr 30
2025
|
Sandra Yvette Campos CEO & President |
SELL
Open market or private sale
|
Direct |
60,463
-4.74%
|
$181,389
$3.32 P/Share
|
|
Apr 09
2025
|
Peter Batushansky Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,527
+50.0%
|
-
|
|
Mar 18
2025
|
Nina Capital Holdings Inc. > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
100,000
+3.85%
|
$400,000
$4.08 P/Share
|
|
Mar 10
2025
|
Nina Capital Holdings Inc. > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
100,000
+4.0%
|
$400,000
$4.11 P/Share
|
|
Mar 03
2025
|
Nina Capital Holdings Inc. > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
50,000
+2.13%
|
$200,000
$4.33 P/Share
|
|
Feb 03
2025
|
Nina Capital Holdings Inc. > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
25,000
+1.1%
|
$100,000
$4.82 P/Share
|
|
Jan 27
2025
|
Nina Capital Holdings Inc. > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
25,000
+1.11%
|
$100,000
$4.63 P/Share
|
|
Jan 24
2025
|
Nina Capital Holdings Inc. > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
25,000
+1.12%
|
$100,000
$4.95 P/Share
|
|
Jan 15
2025
|
Sandra Yvette Campos CEO & President |
BUY
Grant, award, or other acquisition
|
Direct |
146,772
+18.68%
|
-
|
|
Jan 15
2025
|
Jacqueline Paula Smith |
BUY
Grant, award, or other acquisition
|
Direct |
8,000
+22.16%
|
-
|
Last 12 Months Summary
| Open market or private purchase | 849K shares |
|---|---|
| Grant, award, or other acquisition | 407K shares |
| Open market or private sale | 60.5K shares |
|---|